疑似或确诊子痫前期患者并发症预测模型:开发与内部验证
本研究基于前瞻性多中心观察队列,纳入384例20至<37周单胎妊娠疑似或确诊子痫前期(PE)孕妇,开发并内部验证预测7、14、30天内PE相关母婴复合结局的临床模型。模型包含sFlt-1/PlGF比值、孕龄和尿蛋白/肌酐比值,校正后c统计量分别为0.89、0.88和0.87,收缩因子0.91提示过拟合有限。
要点
- sFlt-1/PlGF比值、孕龄和尿蛋白/肌酐比值是PE相关不良结局的重要预测因子。
- 模型对7、14、30天内PE相关并发症的校正c统计量分别为0.89、0.88、0.87。
- 模型区分度良好且过拟合有限(收缩因子0.91),尚待外部验证。
核心结论
- 提出一个简单的临床预测模型,对疑似或确诊PE孕妇的PE相关并发症具有良好区分度。
研究设计与样本
- 数据来自前瞻性多中心观察队列,纳入384例20至<37周单胎妊娠疑似或确诊PE孕妇。
- 采用多变量竞争风险回归开发模型,bootstrap 500次重复内部验证校正乐观度并计算收缩因子。
主要发现
- 384例中96例(25%)入院后发生PE相关不良结局。
- 重要预测因子包括sFlt-1/PlGF比值、生物标志物检测时孕龄和尿蛋白/肌酐比值(均为连续变量)。
- 预测7、14、30天内PE相关并发症的校正c统计量分别为0.89、0.88和0.87。
- 收缩因子为0.91,提示过拟合有限。
临床怎么用
- 模型可用于疑似或确诊PE孕妇的短期(7、14、30天)PE相关母婴并发症风险分层。
- 临床使用前尚需进一步研究和外部验证确定其效用。
局限性
- 仅进行内部验证,尚缺乏外部验证。
- 模型在临床实践中的 usefulness 待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A model that can predict reliably the risk of pre-eclampsia (PE)-related pregnancy complications does not exist. The aim of this study was to develop and validate internally a clinical prediction model to predict the risk of a composite outcome of PE-related maternal and fetal complications within 7, 14 and 30 days of testing in women with suspected or confirmed PE. METHODS: The data for this study were derived from a prospective, multicenter, observational cohort study on women with a singleton pregnancy and suspected or confirmed PE at 20 to < 37 weeks' gestation. For the development of the prediction model, the possible contribution of clinical and standard laboratory variables, as well as the biomarkers soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and their ratio, in the prediction of a composite outcome of PE-related complications, consisting of maternal and fetal adverse events within 7, 14 and 30 days, was explored using multivariable competing-risks regression analysis. The discriminative ability of the model was assessed using the concordance (c-) statistic. A bootstrap validation procedure with 500 replications was used to correct the estimate of the prediction model performance for optimism and to compute a shrinkage factor for the regression coefficients to correct for overfitting. RESULTS: Among 384 women with suspected or confirmed PE, 96 (25%) had an adverse PE-related outcome at any time after hospital admission. Important predictors of adverse PE-related outcome included sFlt-1/PlGF ratio, gestational age at the time of biomarker measurement and protein-to-creatinine ratio as continuous variables. The c-statistics (corrected for optimism) for developing a PE-related complication within 7, 14 and 30 days were 0.89, 0.88 and 0.87, respectively. There was limited overfitting, as indicated by a shrinkage factor of 0.91. CONCLUSIONS: We propose a simple clinical prediction model with good discriminative performance to predict PE-related complications. Determination of its usefulness in clinical practice awaits further investigation and external validation. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Saleh L, Alblas MM, Nieboer D, et al. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model. Ultrasound Obstet Gynecol. 2021. PMID: 33030757. doi:10.1002/uog.23142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。